Overview
Quantabio provides advanced DNA and RNA amplification reagents for PCR, qPCR, RT-PCR, and NGS applications in life sciences and pharmaceutical research. Their proprietary ToughMix and qScript technologies deliver robust performance against PCR inhibitors, supporting pathogen detection, infectious disease assays, and library preparation for Illumina platforms. Products like UltraPlex 1-Step ToughMix enhance CDC protocols for respiratory disease detection, including COVID-19 and influenza.
Frequently asked questions
- What molecular biology reagents does Quantabio offer?
- Quantabio offers ToughMix reagents for PCR/qPCR, qScript reverse transcriptase kits for RT-PCR/cDNA synthesis, UltraPlex 1-Step ToughMix for multiplex assays, and NGS library prep solutions for Illumina platforms.
- Are Quantabio reagents suitable for pathogen detection and clinical labs?
- Yes, their reagents are used in thousands of clinical-translational and public health labs for sensitive pathogen detection in infectious disease assays, including CDC protocols for COVID-19 and influenza differentiation.
- What makes Quantabio products robust for challenging samples?
- Proprietary ToughMix and eQo technologies overcome PCR inhibitors, provide high fidelity, broad dynamic range, and reliable amplification for demanding molecular testing applications.